Coastlands Capital LP - 23 Feb 2026 SCHEDULE 13G Report for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA)

Filing Manager
Coastlands Capital LP
Reporting Manager
Coastlands Capital LP
Security
Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share
Symbol
KTTA
Shares outstanding
23,971,622 shares
Disclosed Ownership
2,394,765 shares
Ownership
10%
Form type
SCHEDULE 13G
Filing time
27 Feb 2026, 16:01:28 UTC
Date of event
23 Feb 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Coastlands Capital LP disclosed 10% ownership in Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA) on 23 Feb 2026."

Quick Takeaways

  • Coastlands Capital LP filed SCHEDULE 13G for Pasithea Therapeutics Corp. Common Stock, par value $0.0001 per share (KTTA).
  • Disclosed ownership: 10%.
  • Date of event: 23 Feb 2026.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 27 Feb 2026, 16:01.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Coastlands Capital LP 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital LLC
Coastlands Capital Partners LP 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Coastlands Capital GP LLC 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer
Coastlands Capital LLC 10% 2,394,765 0 2,394,765 /s/ Mark Shamia Chief Operating Officer
Matthew D. Perry 10% 2,394,765 0 2,394,765 /s/ Matthew D. Perry Reporting Person

Sponsored